BioAmber Inc. Accretion Expense
BioAmber Inc. reported Accretion Expense of $1.03 million for the 12-month period ending 2016-12-31, per its 10-K filed 2018-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AccretionExpense · last filed 2018-03-30
- BioAmber Inc. accretion expense for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- BioAmber Inc. accretion expense for the quarter ending 2016-09-30 was $774.70K, a 350.74% increase year-over-year.
- BioAmber Inc. accretion expense for the quarter ending 2016-06-30 was $129.12K, a 24.88% decline year-over-year.
- BioAmber Inc. accretion expense for the quarter ending 2016-03-31 was $129.12K, a 24.88% decline year-over-year.
- BioAmber Inc. accretion expense for fiscal 2016 was $1.03M, a 0.33% increase from fiscal 2015.
- BioAmber Inc. accretion expense for fiscal 2015 was $1.03M, a 56.78% decline from fiscal 2014.
- BioAmber Inc. accretion expense for fiscal 2014 was $2.38M, a 383.51% increase from fiscal 2013.
- BioAmber Inc. accretion expense for fiscal 2013 was $492.71K.
| Period end | Accretion Expense 3 month | Accretion Expense 6 month | Accretion Expense 9 month | Accretion Expense 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $774.70K derived: sum of 2 quarters · filed 2018-03-30 | $903.82K derived: sum of 3 quarters · filed 2018-03-30 | $1.03M 10-K · filed 2018-03-30 |
| 2016-09-30 | $774.70K 10-Q · filed 2017-11-08 | $903.82K derived: sum of 2 quarters · filed 2017-11-08 | $1.03M 10-Q · filed 2017-11-08 | $1.55M derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-06-30 | $129.12K 10-Q · filed 2017-08-04 | $258.23K 10-Q · filed 2017-08-04 | $772.17K derived: sum of 3 quarters · filed 2018-03-30 | $944.05K derived: sum of 4 quarters · filed 2018-03-30 |
| 2016-03-31 | $129.12K 10-Q · filed 2017-05-10 | $643.05K derived: sum of 2 quarters · filed 2018-03-30 | $814.93K derived: sum of 3 quarters · filed 2018-03-30 | $986.80K derived: sum of 4 quarters · filed 2018-03-30 |
| 2015-12-31 | $513.94K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30 | $685.81K derived: sum of 2 quarters · filed 2018-03-30 | $857.69K derived: sum of 3 quarters · filed 2018-03-30 | $1.03M 10-K · filed 2018-03-30 |
| 2015-09-30 | $171.88K 10-Q · filed 2016-11-07 | $343.75K derived: sum of 2 quarters · filed 2016-11-07 | $515.63K 10-Q · filed 2016-11-07 | $2.18M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $171.88K 10-Q · filed 2016-08-09 | $343.75K 10-Q · filed 2016-08-09 | $2.01M derived: sum of 3 quarters · filed 2017-03-16 | $2.25M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $171.88K 10-Q · filed 2016-05-09 | $1.84M derived: sum of 2 quarters · filed 2017-03-16 | $2.08M derived: sum of 3 quarters · filed 2017-03-16 | $2.32M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.91M derived: sum of 2 quarters · filed 2017-03-16 | $2.15M derived: sum of 3 quarters · filed 2017-03-16 | $2.38M 10-K · filed 2017-03-16 |
| 2014-09-30 | $241.11K 10-Q · filed 2015-11-09 | $479.60K derived: sum of 2 quarters · filed 2015-11-09 | $715.47K 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $238.49K 10-Q · filed 2015-08-05 | $474.36K 10-Q · filed 2015-08-05 | ||
| 2014-03-31 | $235.87K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $492.71K 10-K · filed 2016-03-15 |